16 Healthcare Stocks Moving In Friday's Pre-Market Session

Loading...
Loading...

Gainers

  • Ekso Bionics Holdings, Inc. EKSO stock increased by 19.7% to $0.67 during Friday's pre-market session. The market cap stands at $69.4 million. The most recent rating by Cantor Fitzgerald, on September 06, is at Overweight, with a price target of $1.00.
  • Durect, Inc. DRRX stock surged 15.1% to $1.91. The market cap stands at $124.7 million. The most recent rating by Cantor Fitzgerald, on September 06, is at Overweight, with a price target of $5.00.
  • Neon Therapeutics, Inc. NTGN shares increased by 12.4% to $3.27. The market cap stands at $134.2 million. The most recent rating by Baird, on July 26, is at Outperform, with a price target of $15.00.
  • Kadmon Holdings, Inc. KDMN shares moved upwards by 9.1% to $2.70. The market value of their outstanding shares is at $135.8 million. The most recent rating by Cantor Fitzgerald, on September 06, is at Overweight, with a price target of $8.00.
  • Myovant Sciences, Inc. MYOV shares moved upwards by 8.8% to $8.75. The market cap seems to be at $782.9 million. The most recent rating by Goldman Sachs, on August 28, is at Buy, with a price target of $20.00.
  • DelMar Pharmaceuticals, Inc. DMPI shares rose 6.5% to $0.65.
  • CannTrust Holdings, Inc. CTST stock moved upwards by 4.5% to $1.84. The market cap seems to be at $555.7 million.
  • Mallinckrodt, Inc. MNK stock rose 4.4% to $1.66. According to the most recent rating by BMO Capital, on September 05, the current rating is at Market Perform.
  • DBV Technologies, Inc. DBVT stock rose 2.7% to $10.21. The most recent rating by Goldman Sachs, on June 17, is at Buy, with a price target of $14.00.
  • Livongo Health, Inc. LVGO stock rose 1.8% to $26.00. The market cap stands at $4.0 billion. The most recent rating by Morgan Stanley, on August 28, is at Overweight, with a price target of $42.00.

 

Losers

  • Viveve Medical, Inc. VIVE shares plummeted 10.2% to $0.09 during Friday's pre-market session. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
  • Zafgen, Inc. ZFGN shares fell 5.7% to $0.66. The market cap seems to be at $96.7 million. The most recent rating by Wedbush, on September 06, is at Neutral, with a price target of $0.78.
  • Edesa Biotech, Inc. EDSA stock declined 3.9% to $5.75. The market value of their outstanding shares is at $39.3 million.
  • Turning Point, Inc. TPTX stock decreased by 2.7% to $45.71. The market value of their outstanding shares is at $1.0 billion.
  • uniQure, Inc. QURE shares plummeted 2.4% to $46.50. The market cap stands at $290.3 million. According to the most recent rating by Guggenheim, on July 30, the current rating is at Neutral.
  • Alexion Pharmaceuticals, Inc. ALXN stock decreased by 1.5% to $98.79. The market cap stands at $24.1 billion. The most recent rating by Credit Suisse, on September 06, is at Outperform, with a price target of $146.00.
Loading...
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralBiotechnologyHealth CareHealthcare Stocks Pre-Market MoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...